NF-kappaB pathway inhibitors (ARIAD)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNF-kappaB pathway inhibitors (ARIAD)
Drug Alias NameNF-kB inhibitors (ARIAD)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsProtein kinases inhibitors
TargetsNuclear factor NF-kappa-B complexProtein kinases
Therapy Area/IndicationsInflammationAsthmaArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAriad Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAriad Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationAsthmaArthritis

Other Information

ATC CodeN/A
Related LinksN/A